Peters C, Bruno A, Rizzari C, Brescianini A, von Stackelberg A, Linderkamp C, Zeng Y, Zugmaier G, Locatelli F. Blinatumomab is associated with better post-transplant outcome than chemotherapy in children with high-risk, first-relapse B-cell acute lymphoblastic leukemia irrespective of the conditioning regimen. haematol [Internet]. 2025Jan.1 [cited 2025Jan.15];110(1):234-8. Available from: https://haematologica.org/article/view/haematol.2024.285837